MorphImmune - Crunchbase Company Profile & Funding

Q: When was the last funding round for MorphImmune?

MorphImmune closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has MorphImmune raised to date?

MorphImmune has raised obfuscated.

Overview

MorphImmune

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About MorphImmune

CB Rank

98005

MorphImmune is a preclinical biotechnology company that targets small-molecule therapeutics.

Acquired by

Immunome

Founded

obfuscation

Private

Venture - Series Unknown

West Lafayette, Indiana, United States

1-10

www.morphimmune.com/

Biotechnology

Life Science

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Philip Low: Founder and Director
Past Role: Endocyte, Co-Founder, Chief Science Officer & Board Member
Bruce Turner: Interim Chief Financial Officer and Chief Strategy Officer

Details

Legal Name

MorphImmune, Inc.

Operating Status

Closed

Company Type

For Profit

Founders

Philip Low

About the Company

Morphimmune is a preclinical biotechnology company focused on developing targeted oncology therapeutics. The company’s proprietary Targeted Effector platform selectively delivers payloads to diseased cells. The targeted approach reduces toxicity and increases the efficacy of known effector molecules, ultimately improving outcomes for patients.

Predictions & Insights

Growth Insight

See this Growth Insight

MorphImmune is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - MorphImmune	—	obfuscated obfuscation	—	Venture - Series Unknown